Status:

COMPLETED

Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.

Lead Sponsor:

Asociacion para el Estudio de las Enfermedades Infecciosas

Conditions:

Health Care Worker Patient Transmission

Receptor Site Alteration

Eligibility:

All Genders

18-65 years

Brief Summary

The primary objective of this study is to establish differences in susceptibility to SARS CoV-2 infection among health care workers (HCW) highly exposed to patients with COVID-19 diagnosis. To ascerta...

Detailed Description

Only 24% of health care workers (HCW) had developed inmunological response to SARS CoV-2 infection in one centre attending thousands of COVID-19 patients, and with shorteness of personal protective eq...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • HCW older than 18 years
  • Highly exposed to COVID-19 according to the definition
  • Negative (cases) or positive (controls) serology against SARS-CoV-2 infection Exclusion criteria
  • Presence of any disease / treatment which could alter the susceptibility (corticoid therapy, chemotherapy, monoclonal antibodies)
  • Pregnancy
  • High exposure definition: direct and continued care of COVID-19 diagnosed patients for 2 weeks or more, without aerosol- generating procedures, with inappropriate personal protective equipment (PPE), or unprotected exposure to patients with COVID-19 during aerosol-generating procedures.
  • The definition of appropriate PPE was based on previous recommendations. The absence of any part of the PPE constituted an unprotected exposure. We defined the following as aerosol-generating procedures: airway suction, application of a high-flow O2 instrument, bronchoscopy, endotracheal intubation, tracheostomy, nebulizer treatment, sputum induction, positive pressure ventilation, manual ventilation and cardiopulmonary resuscitation.

Exclusion

    Key Trial Info

    Start Date :

    August 1 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 30 2021

    Estimated Enrollment :

    140 Patients enrolled

    Trial Details

    Trial ID

    NCT04402827

    Start Date

    August 1 2020

    End Date

    September 30 2021

    Last Update

    October 26 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Ramon y Cajal

    Madrid, Spain, 28034